So-Young (SY) Q4 2025: Aesthetic Center Revenue Surges 205%, Shifting Profit Engine and Expansion Playbook

2026-03-25 | By EarningsIQ Research

So-Young’s branded aesthetic center business delivered a breakout quarter, cementing a new core revenue engine and validating its chain model across both tier-one and tier-two cities. Leadership is pivoting from pure scale to margin and network efficiency, with mature centers and core members driving profitability. As the sector resets around value and trust, So-Young’s operational discipline and cost leverage position it to capture outsized share in China’s evolving medical aesthetics market.

Summary

• Aesthetic Center Model Proves Scalable: Mature centers and tier-two city clinics match or exceed first-tier performance, accelerating network profitability.
• Margin Expansion Focus Intensifies: Leadership is shifting from rapid expansion to optimizing center mix, supply chain leverage, and member LTV.
• 2026 Playbook Prioritizes Quality Over Quantity: Expansion will be more measured, with emphasis on operational efficiency and brand-driven user growth.

Performance Analysis

So-Young’s Q4 marked a structural inflection as the branded aesthetic center business became the company’s largest revenue contributor, surging over 205% year-over-year and exceeding internal guidance by 10%. The segment accounted for more than 15% of total revenue, reflecting not only scale but also improved profitability—25 centers achieved profitability and 39 generated positive operating cash flow. Mature centers (17 in total) delivered average revenue nearly double that of growth-phase centers, demonstrating the chain’s inherent operating leverage as clinics mature.

Legacy segments, including information and reservation services and medical products, contracted sharply, with double-digit revenue declines driven by lower equipment order volume and platform transition. However, the core aesthetic center business more than offset these declines, fueling a record high in quarterly revenue and validating management’s strategic pivot. Cost discipline was evident in R&D and operational expenses, while sales and marketing spend increased to support new center launches and brand campaigns. Cash reserves remain robust at $936 million, ensuring ample runway for network expansion and supply chain investment.

• Chain Model Delivers Margin Upside: Average revenue per mature center nearly doubles that of growth-phase clinics, with profitability consistently following network maturity.
• Legacy Platform and Product Segments Weaken: Non-core businesses declined, but their drag was more than offset by the aesthetic center surge.
• Cost Structure Shows Operating Leverage: R&D and G&A were well managed, while targeted marketing spend underpinned user and member growth.

Overall, the results signal a successful transition from platform to operator, with the chain model’s economics now driving the group’s growth and margin story.

Executive Commentary

Strategic Positioning

1. Branded Aesthetic Center Network as Core Engine

So-Young’s transformation into a clinic operator is now complete, with 49 centers across 15 cities and the aesthetic segment delivering the majority of group revenue. The chain model, defined as a standardized, replicable clinic network, delivers both operational consistency and rapid user acquisition, with mature centers driving margin expansion and cash flow. Management’s focus is now on deepening density in major cities and replicating the model in tier-two markets, where early results show profitability and user metrics rivaling top-tier locations.

2. Margin and Efficiency Over Pure Scale

Leadership is recalibrating expansion pace to prioritize margin and network efficiency. New center launches will comprise a smaller share of the network in 2026, reducing ramp-up drag on group margins. Mature centers’ contribution will rise, while supply chain scale and blockbuster product strategies further compress procurement costs. The company’s “blockbuster product” approach—focused on high-volume, high-margin treatments—delivered over 37% of segment revenue in Q4, demonstrating its ability to drive both top-line and efficiency gains.

3. Member System and LTV Focus

Membership and user retention are central to the company’s growth strategy. Core members (level 3 and above) now account for a growing share of revenue, with quarterly repurchase rates exceeding 80%. The company is rolling out tiered benefits, product bundles, and co-branded campaigns (e.g., with Little Prince and Disney) to deepen loyalty and drive repeat spend. This user-centric model lowers customer acquisition costs (kept below 10% of revenue) and builds a durable LTV engine as the network scales.

4. Supply Chain and Brand Leverage

So-Young’s direct procurement and exclusive distribution partnerships (e.g., Xihong Biopharma) provide a cost and product differentiation moat. The company’s ability to secure best-tier pricing and launch exclusive products (such as Miracle PLLA and proprietary HA solutions) supports both margin and user experience. Offline brand presence in premium malls across China further cements its positioning with target customers.

5. Second-Tier City Expansion Validates Model

Operational data from tier-two city clinics confirm that the chain model is portable and profitable beyond China’s largest metros. Centers in cities like Wuhan and Suzhou achieved revenue and profitability levels on par with or exceeding first-tier peers, with lower rental and payroll costs providing a margin tailwind. This supports management’s thesis that scale, standardization, and trust can unlock underpenetrated markets and drive network-wide returns.

Key Considerations

This quarter marks a strategic inflection for So-Young as it pivots from platform to chain operator, with implications for margin structure, competitive positioning, and capital allocation in 2026.

Key Considerations:

• Center Maturity Drives Financial Trajectory: As more clinics transition from growth to mature phase, group revenue per center and margin profile are set to improve further.
• Second-Tier Cities Offer Margin Upside: Lower costs and strong demand in these markets validate the model’s scalability and may become a profit lever as expansion accelerates.
• Member and Brand Flywheel: High repurchase rates and co-branded campaigns reduce acquisition costs and build sticky, high-value user cohorts.
• Blockbuster Product Strategy: Focus on high-margin, high-volume treatments supports both revenue growth and procurement cost leverage.
• Legacy Segment Drag: Platform and product businesses are shrinking, increasing reliance on execution in the core clinic segment.

Risks

Execution risk remains high as the company shifts from rapid buildout to margin optimization, especially with the planned addition of at least 35 new centers in 2026. Regulatory uncertainty, especially around medical compliance and data security, could impact expansion plans. Legacy business declines increase dependence on the aesthetic center network, raising concentration risk if consumer demand or competitive intensity shifts.

Forward Outlook

For Q1 2026, So-Young guided to:

• At least 35 new clinic openings for the full year, with a more balanced cadence to minimize margin drag.
• Continued improvement in gross margin as mature centers comprise a larger share of the network.

For full-year 2026, management emphasized:

• Focus on margin and efficiency over pure scale, with a goal of proving the model’s profitability at network level.
• Further leverage of supply chain and blockbuster product strategy to compress costs and drive user value.

Management highlighted that systematic capabilities built over the past two years provide confidence in both profitability and sustainable growth, with a strong cash position to fund expansion and product launches.

Takeaways

So-Young’s Q4 results confirm the branded aesthetic center network as a scalable, profitable growth engine, with the chain model now validated in both top-tier and emerging city markets.

• Margin Expansion in Focus: Mature center mix, supply chain leverage, and member-driven LTV are set to drive further profitability in 2026.
• Operational Discipline Will Be Tested: The shift from platform to operator raises the bar for execution, especially as legacy segments shrink.
• Watch for Member System and Tier-Two City Performance: Sustained high repurchase rates and successful new city launches will be the key signals for ongoing network health and upside potential.

Conclusion

So-Young has crossed an inflection point, with its branded aesthetic center business now the undisputed growth and profit driver. The company’s disciplined approach to network maturity, margin optimization, and user retention positions it well for the next phase, though execution risk rises as the model scales across new markets and regulatory scrutiny remains elevated.

Industry Read-Through

So-Young’s results signal a broader re-rating for China’s medical aesthetics sector, with value, trust, and brand now trumping pure volume growth. The chain model’s operational leverage and member-centric playbook are likely to become industry norms, raising the bar for smaller, single-center operators. Supply chain integration and exclusive product partnerships are emerging as key differentiators, with scale players best positioned to capture procurement and marketing advantages. For investors and competitors alike, the focus is shifting from land-grab expansion to sustainable, margin-accretive growth, especially as consumer behavior normalizes and regulatory oversight intensifies.

SY Health Care Medical Aesthetics Chain Model Membership Margin Expansion China